Skip to main content
GrantsPathGrantsPath
Log InSign Up

Policy Watchtower/Funding available

NIH forecasts R61/R33 clinical trial funding; tribal governments among eligible

National Institutes of HealthFunding availableSep 29, 2026

Check: The National Institutes of Health (NIH) plans a two-phase clinical trial funding opportunity that lists tribal governments that are not federally recognized as eligible applicants, but applications are not open yet.

Read the original

What it does

A forecast notice says NIH intends to publish a (, the formal announcement that solicits applications) for early to definitive clinical trials using the R61/R33 activity code, a two-phase award where the R61 phase funds planning and the R33 phase funds the trial. Tribal governments that are not federally recognized are among the listed eligible applicants, and the notice encourages potential applicants to build collaborations now. Estimated posting is 2027-05-31 with an estimated application due date of 2027-07-31.

Why it matters for tribal funding

Tribes eligible. Tribes or Native organizations are among those who can apply or are covered, alongside others.

Who it covers: Tribal governments.

: 93.866

What to do next

  1. Confirm whether your organization fits the listed eligibility category, Indian/Native American Tribal Governments (Other than Federally Recognized), before planning a trial partnership.
  2. Begin developing clinical trial partnerships and stakeholder collaborations ahead of the estimated posting date of 2027-05-31, watching for the published under opportunity number PAR-28-074.

Sources

Every signal is built from public records. The highlighted words appear in the source exactly as shown.

  • Grants.gov: forecasted opportunitiesforecastSep 29, 2026

    Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

    • Quoted from the source: “Applications are not being solicited at this time.”
    • Quoted from the source: “Indian/Native American Tribal Governments (Other than Federally Recognized)”
    • Quoted from the source: “The R61 phase provides support for planning activities, and the R33 phase provides support for a clinical trial, with a maximum project period of 7 years.”
    Read the originalU.S. government record, public domain.

Terms with a dotted underline open a plain-language definition. This is guidance, not legal advice: the official text always controls. A free public service from GrantsPath, a Native-owned business.